Innovating Works
PRISM 2: Psychiatric Ratings using Intermediate Stratified Markers 2 BIOTRIAL NEUROSCIENCE participó en un H2020 H2020-JTI-IMI2-2020-22-single-stage The current nosology of neuropsychiatric disorders provides a pragmatic approach to diagnosis and treatment choice but lacks reference to qu...
2021-05-19 - 2024-11-30 | Financiado
PRIME: Prevention and Remediation of Insulin Multimorbidity in Europe BIOTRIAL NEUROSCIENCE participó en un H2020 H2020-SC1-BHC-2018-2020 PRIME introduces the novel concept of insulin signalling as a key mechanism underlying the multimorbidity of major mental and somatic illnes...
2019-12-06 - 2024-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.